HSK41959 With Standard Therapy in Solid Tumors With MTAP Deletion

NCT07699757 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

258

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Small Cell Lung Cancer
Pancreatic Ductal Adenocarcinoma (mPDAC)
Advanced Solid Tumors

Interventions

DRUG: HSK41959
DRUG: Sintilimab
DRUG: Pemetrexed + Cisplatin /Carboplatin
DRUG: Paclitaxel + Carboplatin
DRUG: Nab-paclitaxel + Carboplatin
DRUG: Nab-paclitaxel + Gemcitabine
DRUG: Docetaxel

Sponsor

Haisco Pharmaceutical Group Co., Ltd.